Baird Financial Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,553
Closed -$215K 1912
2021
Q4
$215K Sell
2,553
-10
-0.4% -$842 ﹤0.01% 1798
2021
Q3
$231K Buy
+2,563
New +$231K ﹤0.01% 1761